Bonesupport Holding AB (publ) (LON:0RQO)

Market Cap	988.95M -38.3%
Revenue (ttm)	94.69M +30.7%
Net Income	11.46M +6.3%
EPS	0.05 -67.2%
Shares Out	n/a
PE Ratio	86.30
Forward PE	41.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,822
Average Volume	32,163
Open	189.30
Previous Close	184.14
Day's Range	182.50 - 193.90
52-Week Range	167.55 - 345.80
Beta	0.43
RSI	49.01
Earnings Date	Apr 22, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1999
• Employees: 148
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RQO

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.

Financial numbers in SEK